Last Trade: 44.35
Trade Time: May 23 4:03 PM Eastern Daylight Time
Change: 0.33 (0.75 %)
Prev Close: 44.02
Open: 43.68
Bid: 40.14
Ask: 46.00
Quotes displayed are delayed by 15 minutes. Market data is provided by Telvent DTN

ETF Alternatives

Ticker Name Weight % Change
No ETF alternatives available.


People viewing CRL also viewed: , , , ,

Competitors

Ticker Name Volume % Change
ADEC ALTERNATIVE ENERGY 219.0 +1.00%
DNAG DNA PRINT GENOMICS 93.6K +1.00%
PRTX PROTALEX 4.1K +0.10%
THERF THERATECHNOLGIES INC 2.0K +0.08%
SNTI SENESCO TECHNOLOGIES 470.8K +0.05%

Insider Transactions

Date Name Title Volume Trade Price Holding Change
5/14/2013 FOSTER JAMES C Chairman, President and CEO 113,810 $38.03 31.05%
5/14/2013 FOSTER JAMES C Chairman, President and CEO -113,810 $45.00 -23.69%
5/10/2013 MASSARO GEORGE Director -200 $44.10 -0.89%
5/10/2013 MASSARO GEORGE Director -133 $44.16 -0.60%
5/10/2013 MASSARO GEORGE Director -87 $44.08 -0.39%
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (CRL), click here.

CRL Stock Analysis

  1. The “Healthy” Play In Contract Research Organizations

    The pharmaceutical industry is under pressure to do more with less. That means it will be farming out many of is mundane clinical trial and lab work. This outsourcing will be a big win for the contract research organizations.
Free Reports
  1. Free Investment Report: 6 Must-Own Emerging Market Stocks

    Gain Valuable Insights into International and Emerging Markets That are Poised for Explosive Growth!
  2. 7 Proven Strategies for Market-Stomping Stocks

    Discover Investing Strategies that will Benefit Every Investor Today!
  3. 3 Stocks Peter Lynch Would Buy Today

    This new special report identifies 3 stocks based on Lynch’s market-trouncing strategy that could more than double in the next 12 months.
Marketplace
Trading Center